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Introduction
The  nervous  system  responds  to  experience  by  altering  the 
number and strength of synaptic connections (Katz and Shatz, 
1996). Activity-dependent synaptic stabilization and elimina-
tion play a critical role in shaping patterns of neuronal connec-
tions during brain development (Constantine-Paton et al., 1990; 
Lichtman and Colman, 2000; Debski and Cline, 2002; Goda 
and Davis, 2003; Hensch, 2005; Taha and Stryker, 2005).   
Although the molecular mechanisms by which neuronal activ-
ity alters synaptic connectivity remains largely unknown, it is 
believed that postsynaptic cells often generate positive and neg-
ative signals that retrogradely alter presynaptic structure and 
function (Balice-Gordon et al., 1993; Lo et al., 1994).
Using Xenopus laevis nerve–muscle coculture as a model 
system, Lo et al. (1994) and Cash et al. (1996) elegantly demon-
strated that postsynaptic activity is critical for synaptic depres-
sion, a process which may be important for proper development 
of neuronal circuits. For example, prolonged postsynaptic stim-
ulation of myocytes results in a significant and sustained reduc-
tion in synaptic efficacy (Dan and Poo, 1992; Lo and Poo, 1994; 
Lo et al., 1994). Inhibition of postsynaptic Ca
2+ rise by the Ca 
buffer BAPTA prevents synaptic depression, whereas an increase 
in cytosolic Ca
2+ by photo-uncaging in the postsynaptic myo-
cytes is sufficient to induce persistent synaptic depression (Cash 
et al., 1996). These results suggest that postsynaptic Ca
2+ sig-
naling is important for the release of a retrograde factor, which 
in turn acts on presynaptic terminals to induce synaptic depres-
sion (Dan et al., 1995; Poo, 2001). Furthermore, a brief presyn-
aptic stimulation induces synaptic potentiation, which is also 
dependent on postsynaptic Ca
2+ and retrograde signaling (Wan 
and Poo, 1999). However, the nature of the retrograde factor has 
not been established.
Neurotrophins have been recognized as key regulators of 
synapse development and plasticity (Poo, 2001; Lu, 2003). One 
such factor, brain-derived neurotrophic factor (BDNF), elicits a 
rapid increase in transmitter release by activating presynaptic 
  P
ostsynaptic  cells  generate  positive  and  negative 
signals that retrogradely modulate presynaptic func-
tion. At developing neuromuscular synapses, pro-
longed  stimulation  of  muscle  cells  induces  sustained 
synaptic depression. We provide evidence that pro–brain-
derived neurotrophic factor (BDNF) is a negative retro-
grade signal that can be converted into a positive signal 
by metalloproteases at the synaptic junctions. Application 
of pro-BDNF induces a dramatic decrease in synaptic ef-
ficacy followed by a retraction of presynaptic terminals, 
and  these  effects  are  mediated  by  presynaptic  pan- 
neurotrophin receptor p75 (p75
NTR), the pro-BDNF receptor. 
A brief stimulation of myocytes expressing cleavable   
or uncleavable pro-BDNF elicits synaptic potentiation 
or depression, respectively. Extracellular application of 
metalloprotease inhibitors, which inhibits the cleavage of   
endogenous pro-BDNF, facilitates the muscle stimulation–
induced synaptic depression. Inhibition of presynaptic 
p75
NTR or postsynaptic BDNF expression also blocks the 
activity-dependent synaptic depression and retraction. 
These results support a model in which postsynaptic secre-
tion  of  a  single  molecule,  pro-BDNF,  may  stabilize  or 
eliminate presynaptic terminals depending on its proteo-
lytic conversion at the synapses.
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A previous study indicated that spinal motor neurons express a 
high level of p75
NTR during early development, but its expres-
sion subsides after the formation of NMJs postnatally (Yan and 
Johnson, 1988). Indeed, p75
NTR was strongly expressed in the 
developing spinal neurons, particularly at the presynaptic termi-
nals that innervated the myocytes (Fig. S1 B). We next exam-
ined the expression and secretion of pro-BDNF, the ligand for 
p75
NTR. In Xenopus nerve–muscle cultures, immunofluorescence 
staining under membrane permeable conditions detected pro-
BDNF in postsynaptic muscle cells but not at the presynaptic 
terminals (Fig. S1 C). Western blot analysis revealed the expres-
sion of pro-BDNF in muscle tissues in vivo in various stages of 
Xenopus development (Fig. S1 D).
Synaptic depression induced by exogenous 
pro-BDNF
To determine the functional role of pro-BDNF, we applied a   
recombinant, cleavage-resistant pro-BDNF (Woo et al., 2005)   
to Xenopus nerve–muscle cocultures. Spontaneous synaptic cur-
rents (SSCs) and impulse-evoked synaptic currents (ESCs) were 
monitored using whole-cell voltage clamp (Yang et al., 2001). 
The application of 2 ng/ml pro-BDNF markedly inhibited spon-
taneous synaptic transmission recorded in the presence of 1 µM 
tetrodotoxin (Fig. 1 A). The mean SSC frequency was 11.8 ± 1.2 
events/min before pro-BDNF application, but it decreased to 2.9 ± 
0.4 events/min 40 min after pro-BDNF application (P < 0.001; 
t test). This decrease in synaptic efficacy is not caused by a toxic 
side effect of pro-BDNF because the treatment of the cultures 
with pro-BDNF for >24 h did not induce obvious apoptosis of 
the spinal neurons or myocytes (Fig. S1 E). Furthermore, pro-
BDNF–mediated synaptic depression was recovered after wash-
ing out pro-BDNF within 5–10 min (Fig. 1, A and B), which 
argued against an apoptotic effect of pro-BDNF. In addition to 
the SSC frequency, the application of pro-BDNF markedly re-
duced SSC amplitude (P < 0.02; Fig. 1 C). Several experiments 
were performed to determine the underlying mechanisms by which 
pro-BDNF elicits synaptic depression. The kinetics of FM dye 
destaining was the same in control and pro-BDNF–treated 
groups (Fig. S2), suggesting that the probability of presynaptic 
transmitter release is not altered by pro-BDNF treatment. More-
over, acetylcholine receptor (AChR) clusters, labeled by a low 
concentration of rhodamine-conjugated -bungarotoxin (-BTX; 
100 nM), were not dispersed after pro-BDNF treatment, even 
after axonal retraction had occurred (Fig. S3). Thus, postsynap-
tic dispersion of AChRs was not the cause for synaptic depression. 
Finally, the analysis of SSC kinetics revealed that pro-BDNF 
increased both the rise and decay times of SSCs (Fig. 1 D). This 
result, together with the dramatic decrease in SSC frequency in-
duced by pro-BDNF, supports the notion that the distance be-
tween pre- and postsynaptic membranes might become wider. 
However, we cannot completely rule out the possibility that pro-
BDNF may induce a switch of transmitter release from synaptic 
to extrasynaptic site.
To determine the role of pro-BDNF in functional synaptic 
transmission, we measured the amplitude of ESCs elicited by 
stimulating presynaptic somata of spinal neurons (Yang et al., 
2001). Application of pro-BDNF dramatically reduced ESC 
tropomyosin-related kinase (Trk) B receptors when applied 
acutely to the neuromuscular synapses (Lohof et al., 1993). 
In addition, long-term BDNF treatment promotes synapse mat-
uration (Wang et al., 1995). Similar to other neurotrophins, BDNF 
is initially synthesized as a precursor (pro-BDNF), which is sub-
sequently cleaved to generate mature BDNF (mBDNF). Pro-BDNF 
interacts preferentially with the pan-neurotrophin receptor p75 
(p75
NTR), whereas mBDNF selectively binds and activates the 
receptor Tyr kinase TrkB (Chao and Bothwell, 2002; Ibanez, 
2002). Cumulative evidence supports a “yin-yang” hypothesis, 
in which pro- and mBDNF elicit opposite biological effects by 
activating two distinct receptor systems (Lu et al., 2005). For 
example, activation of p75
NTR, most likely by endogenous pro-
BDNF, appears to be critical for long-term depression in the 
hippocampus (Rosch et al., 2005; Woo et al., 2005). In contrast, 
mBDNF-TrkB signaling is essential for the early phase of long-
term potentiation (LTP; Korte et al., 1995; Figurov et al., 1996; 
Patterson et al., 1996). Although the secretion of pro-BDNF 
was initially questioned (Matsumoto et al., 2008), substantial 
evidence now demonstrates that a significant proportion of 
BDNF in the brain is secreted in the pro form (Teng et al., 2005; 
Nagappan et al., 2009; Yang et al., 2009). Moreover, extracellu-
lar conversion of pro-BDNF to mBDNF by the tissue plasmino-
gen activator/plasmin protease system is critical for late-phase 
LTP (Pang et al., 2004). The expression of pro-BDNF and 
p75
NTR in rodents is developmentally regulated, with the highest 
levels in the first and second postnatal week, correlating well 
with synapse formation and elimination (Yang et al., 2009).   
In this study, we sought to test the hypothesis that pro-BDNF is 
a retrograde signal that induces synaptic depression after post-
synaptic stimulation at the neuromuscular synapse. We demonstrate 
that exogenous pro-BDNF suppresses synaptic transmission and 
structurally causes axonal retraction by activating presynaptic 
p75
NTR. We provide evidence that muscle stimulation induces 
secretion of pro-BDNF, which elicits either synaptic potentia-
tion or depression depending on whether it is proteolytically 
cleaved. Metalloproteases appear to be a major class of prote-
ases mediating pro-BDNF to mBDNF conversion at the neuro-
muscular junction (NMJ). These findings provide mechanistic 
insight into how positive and negative signals could be derived 
from the same molecule and suggest that proteolytic cleavage of 
pro-BDNF is an important regulatory step in BDNF signaling 
and synapse refinement.
Results
Expression of TrkB, p75
NTR, and pro-BDNF 
at Xenopus neuromuscular synapses
Xenopus nerve–muscle coculture is a well suited system to study 
activity-dependent synaptic modulation and synaptic actions of 
neurotrophins (Lo and Poo, 1991, 1994; Lohof et al., 1993; 
Lo et al., 1994; Wang et al., 1995; Je et al., 2006). In this sys-
tem, mBDNF elicits an acute effect on synaptic transmission 
and long-term effects on synapse maturation through the activa-
tion of presynaptic TrkB (Lohof et al., 1993; Wang et al., 1995). 
Consistent with this, we detected strong TrkB immunoreactivity 
in presynaptic neurons as well as at the NMJ in culture (Fig. S1 A). 729 PRO-BDNF–INDUCED SYNAPTIC DEPRESSION AND RETRACTION • Yang et al.
Pro-BDNF–induced synaptic depression is 
mediated by p75
NTR
To determine whether pro-BDNF induces synaptic retraction by 
activating p75
NTR, we designed an siRNA against both Xenopus 
p75NTRa and p75NTRb genes (Hutson and Bothwell, 2001). 
The embryo injection at the two-cell stage was used to intro-
duce the siRNA into either neurons or myocytes (see Materials 
and methods; Yang et al., 2001). Western blot analysis revealed 
amplitude (Fig. 1, E and F). The amplitude was 2,182 ± 196 pA 
in control but 1,228 ± 92 pA 10 min after pro-BDNF treatment 
(P < 0.0001). Moreover, pro-BDNF significantly increased the 
delay of onset (Fig. 1 F), which also indicated the widening of syn-
aptic clefts. Collectively, these results suggested that pro-BDNF 
may cause the physical retraction of presynaptic terminals from 
postsynaptic muscle cells rather than a suppression of synaptic 
transmission by modifying either pre- or postsynaptic elements.
Figure 1.  Synaptic depression induced by pro-BDNF application. Data from individual synapses were averaged from 10 min of recording before and 
30 min after pro-BDNF treatment. All data are presented as mean ± SEM. The number associated with each bar in the graphs represents the number of 
cells analyzed. The asterisks indicate a significantly higher result than that for the respective “before treatment” group by a t test (*, P < 0.05). (A) Sample 
recordings of SSCs from a neuromuscular synapse before and after the application of cleavage-resistant pro-BDNF. The top recording shows a rapid and 
persistent decrease in SSC frequency after pro-BDNF application, whereas the bottom recording demonstrates the recovery of synaptic efficacy after wash-
out of pro-BDNF from the culture. (B) Time course of pro-BDNF–induced synaptic depression. Each point represents the mean frequency of SSCs (every   
2 min) for 10 min before and 40 min after pro-BDNF treatment. After washout of pro-BDNF from culture within 5–10 min (closed square), the synaptic efficacy 
was recovered. However, after pro-BDNF washout after 10 min (closed circle), the synaptic depression persisted. The numbers in parentheses indicate the 
number of synapses recorded. (C) Effect of pro-BDNF on SSC amplitude. (D) Effect of pro-BDNF on rise time and decay time of SSCs. (E) Superimposed 
traces of ESCs before and 30 min after pro-BDNF treatment. (F) Amplitude and delay of onset of ESCs before and after pro-BDNF treatment.JCB • VOLUME 185 • NUMBER 4 • 2009   730
expressed in either presynaptic spinal neurons or postsynaptic 
muscle  cells,  as  indicated  by  coexpressed  GFP.  Neuronal   
expression of p75
NTR siRNA but not scrambled siRNA pre-
vented pro-BDNF–induced synaptic depression (Fig. 2 B). 
However, the expression of p75
NTR siRNA in postsynaptic mus-
cle cells did not prevent pro-BDNF–induced synaptic depres-
sion (Fig. 2 B). To confirm the specificity of p75
NTR siRNA, we 
performed rescue experiments by coexpressing p75
NTR siRNA 
with rat p75
NTR mRNA in presynaptic neurons because nucleotide 
an 40% reduction of endogenous p75
NTR in homogenates of 
neural tubes derived from embryos injected with p75
NTR siRNA 
(Fig. 2 A). Because only a fraction of the cells in the injected 
embryos received p75
NTR siRNA, the actual down-regulation of 
p75
NTR in an individual cell, which contains siRNA, should 
be far more pronounced. As a control, injection of scrambled 
siRNA into the embryos failed to down-regulate p75
NTR expres-
sion (Fig. 2 A). The injected embryos were used to prepare nerve–
muscle cocultures in which the p75
NTR siRNA was selectively 
Figure 2.  Pro-BDNF–mediated synaptic depression is medi-
ated by presynaptic p75
NTR. (A) Down-regulation of p75
NTR 
by  siRNA.  p75
NTR-specific  siRNA  and  scrambled  (Scrm.) 
analogues  were  introduced  into  the  developing  Xenopus 
by embryo injection. Neural tubes were dissected, and pro-
teins  were  extracted.  Western  blots  were  performed  using 
anti-p75
NTR–specific  antibody  together  with  an  antitubulin 
antibody for loading controls. Note a reduction of p75
NTR 
expression in p75
NTR siRNA–injected but not in uninjected 
(control [Ctl.]) or scrambled siRNA–injected embryos (left). 
Quantitative analysis of p75
NTR expression in four indepen-
dent  experiments  (right)  is  shown.  The  number  in  the  bar 
indicates the number of Western blots performed. (B) Attenua-
tion of pro-BDNF effect on SSCs by presynaptic expression of   
siRNA and its rescue by coexpression with rat p75
NTR. p75
NTR 
siRNA was expressed in presynaptic neurons (N+), post-
synaptic myocytes (M+), or not at all (N). Scrambled p75
NTR 
siRNA was used as a control. In the last set of experiments, 
coexpression  of  p75
NTR  siRNA  with  rat  p75
NTR  mRNA  re-
versed the effect of p75
NTR siRNA. (C) Effect of p75
NTR siRNA 
on pro-BDNF–induced depression of ESCs. Amplitude (left) 
and delay of onset (right) of ESCs at control synapses (N) 
and synapses expressing p75
NTR siRNA (N+) are presented. 
The numbers in the bars indicate the number of synapses re-
corded. (A–C) Error bars represent SEM. *, P < 0.05.731 PRO-BDNF–INDUCED SYNAPTIC DEPRESSION AND RETRACTION • Yang et al.
To further confirm that pro-BDNF–induced synaptic retrac-
tion is mediated by p75
NTR, we performed time-lapse imaging   
on synapses expressing p75
NTR siRNA. The pro-BDNF–induced 
synaptic retraction was blocked by presynaptic expression of 
p75
NTR siRNA but not by scrambled siRNA (Fig. 3 B). 1 h after 
pro-BDNF  treatment,  neurons  expressing  presynaptic  p75
NTR 
siRNA did not show axonal retraction (Fig. 3, B and C). Instead, 
some of the terminals exhibited elongation or expansion of axo-
nal terminals (Fig. 3 B). Collectively, these results suggest that 
pro-BDNF triggers physiological depression of neuromuscular 
synapses and morphological retraction of presynaptic terminals 
via activation of p75
NTR in the presynaptic sites.
Synaptic depression and retraction 
triggered by pro-BDNF from  
postsynaptic myocytes
To gain insight into the mechanisms by which pro-BDNF regu-
lates synaptic retraction, we investigated whether postsynaptic 
muscle cells secrete pro-BDNF upon stimulation. Because of 
the lack of pro-BDNF–specific ELISA detection and a limited 
number of muscle cells in the Xenopus cocultures (<1,000 myo-
cytes),  biochemical  measurement  of  activity-dependent  pro-
BDNF secretion from muscle cells was not feasible. Instead, we 
measured endogenous pro-BDNF secretion using an established 
cell surface–staining method based on the fact that pro-BDNF 
is positively charged at physiological pH and could be associ-
ated with cell surface membrane after its secretion (Nagappan 
et al., 2009). The muscle cell cultures were depolarized by high 
K
+ (50 mM) for 5 min, briefly fixed, and processed for cell sur-
face immunofluorescence staining under membrane-impermeable 
conditions using a pro-BDNF–specific antibody. Western blotting 
of brain homogenates from wild-type and BDNF mutant mice 
indicated that this antibody specifically detects pro-BDNF but 
not mBDNF (Nagappan et al., 2009). Under the cell-impermeable 
conditions, antibodies against intracellular protein such as MAP2 
or tau could not detect any signal in neurons in the same dish, 
suggesting that they did not penetrate into cells (unpublished 
data). At resting state, pro-BDNF was barely detectable on the 
muscle surface (Fig. S4 A). Upon depolarization, the cell sur-
face pro-BDNF signal increased dramatically (88%) compared 
with that of unstimulated muscle cells (Fig. S4, B and C). This 
increase was much more pronounced when the cleavage of   
pro-BDNF by matrix metalloproteases (MMPs) was blocked 
(MMP-I; Fig. S4, B and C).
Previous studies have shown that a prolonged, repetitive 
depolarization of postsynaptic muscle cells (2–6 Hz and >900-
3,000 pulses) induced a sustained synaptic depression (Lo and 
Poo, 1991; Lo et al., 1994; Cash et al., 1996). A similar ap-
proach was used to determine whether activity-induced synap-
tic depression is caused by the secretion of pro-BDNF from the 
myocytes. Whole-cell recording was switched to the current-
clamp mode after a period of voltage-clamp recording, and re-
petitive stimulation was applied to induce action potentials in 
myocytes (Fig. 5 A). Changes in SSC frequency observed 
before and after a single episode of muscle stimulation were 
monitored. We found that synaptic depression depends on the 
number of depolarizing pulses applied to the postsynaptic 
sequences corresponding to the siRNA against Xenopus p75
NTR 
were not found in the rat p75
NTR homologue. Neurons express-
ing both p75
NTR siRNA and rat p75
NTR mRNA exhibited pro-
BDNF–induced synaptic depression, indicating the specificity 
of p75
NTR siRNA (Fig. 2 B). Furthermore, similar results were 
obtained using the p75
NTR morpholino that selectively down-
regulates p75
NTR expression in Xenopus embryos (unpublished 
data). Therefore, pro-BDNF–induced synaptic inhibition is me-
diated by presynaptic but not postsynaptic p75
NTR. Expression 
of p75
NTR siRNA in presynaptic neurons also attenuated the de-
crease in ESC amplitude by pro-BDNF (Fig. 2 C). The changes 
in ESC delay of onset induced by pro-BDNF were also reversed 
by presynaptic expression of p75
NTR siRNA (Fig. 2 C). It was 
interesting to note that there was an 40% increase in ESC 
amplitude at synapses in which the presynaptic neurons ex-
pressed p75
NTR siRNA (Fig. 2 C). Based on the inhibitory effect 
of pro-BDNF, this may be caused by the minute, constitutive 
release of muscle-derived endogenous pro-BDNF, which would 
dampen the baseline synaptic transmission, and expression of 
p75
NTR siRNA, which would remove this inhibitory effect of 
endogenous pro-BDNF.
Pro-BDNF–induced retraction of 
presynaptic terminals are also mediated  
by p75
NTR
To test whether pro-BDNF causes the morphological retrac-
tion of presynaptic terminals from recorded muscle cells, we 
labeled presynaptic neurons with GFP (green) by embryo injec-
tion. The synaptic sites were visualized by labeling postsynap-
tic AChRs with a low concentration of -BTX (100 nM), which 
blocked only 30% of neurotransmission at these synapses 
(Walsh and Lichtman, 2003; unpublished data). Phototoxic-
ity was rarely observed, and synaptic terminals did not exhibit 
any gross abnormality over extended fluorescence imaging ses-
sions (>4 h). However, upon application of pro-BDNF, axon 
terminals actively retracted from postsynaptic sites (Fig. 3 A). 
Synaptic retraction was defined as withdrawal of the nerve ter-
minal from the synaptic site by 1 µm. Within 30 min, synaptic 
contacts (Fig. 3 A, yellow-colored areas) were reduced dramati-
cally.  By  60  min,  some  withdrawing  axons  exhibited  thick 
bulges that resembled retraction bulbs (Fig. 3 A). Unlike pro-
BDNF–induced synaptic depression (Fig. 3 B), morphological 
retraction of presynaptic terminals occurred at a slower rate 
(t1/2 = 35 min) than the physiological synaptic depression. Once 
the synaptic retraction occurred, the washout of pro-BDNF 
did not reverse axonal retraction (Fig. S3). It is important to 
note that neuronal soma remained healthy for hours after the 
application of pro-BDNF (Fig. 3 A, right). To further confirm 
that the retraction reflects an early stage of terminal withdrawal 
from synaptic sites, we simultaneously recorded SSCs while 
imaging axonal retraction. We found that pro-BDNF–induced 
synaptic depression occurred before terminal retraction (Fig. 4), 
supporting a notion that synaptic depression is a prelude that 
set the stage for synaptic retraction. Collectively, our physio-
logical and morphological data suggested that cleavage-resistant 
pro-BDNF promotes retraction of nerve terminals from post-
synaptic sites.JCB • VOLUME 185 • NUMBER 4 • 2009   732
To study the role of pro-BDNF cleavage in synaptic depression, 
we expressed cDNAs of cleavable (pro-BDNF–GFP) or cleavage-
resistant (AA–pro-BDNF–GFP) pro-BDNF in muscle cells 
myocytes: although a mild stimulation (1 Hz and 30 pulses) did 
not induce any change in synaptic efficacy, stronger stimulation 
(>960 pulses) reliably induced synaptic depression (Fig. S5 A). 
Figure 3.  Pro-BDNF–induced synaptic retraction mediated by presynaptic p75
NTR. (A) Time-lapse images showing the retraction of a nerve terminal from 
its target myocyte (M) after pro-BDNF treatment. The spinal neuron (N) is labeled with GFP (green), and AChRs on the postsynaptic membrane are labeled 
with rhodamine-conjugated -BTX (red). Pro-BDNF was applied at time 0. Enlarged images of an area within the white box are shown at the left and 
were captured at the indicated times (shown in minutes) after pro-BDNF application. The GFP-labeled axonal terminal (yellow arrows) clearly occupied 
the synaptic site (colocalized with AChRs; yellow) before treatment but progressively withdrew from the junction after pro-BDNF treatment. Note that the 
cell body of the neuron remained healthy even after 2 h. (B) Time-lapse images showing that pro-BDNF failed to induce retraction of an axon of a neuron 
expressing p75
NTR siRNA. Note that upon application of pro-BDNF, the terminals either did not retract (white arrows) or continued to extend further (white 
arrowheads). The inset is magnified to show more detailed images of the synapses. (C) Time course of synaptic retraction under different conditions. The 
number of experiments performed in each condition is indicated in parentheses. Error bars represent SEM. Scrm., scrambled. Bars, 10 µm.733 PRO-BDNF–INDUCED SYNAPTIC DEPRESSION AND RETRACTION • Yang et al.
pre- or postsynaptic cells. Synaptic depression was induced by 
strong depolarization applied to myocytes (1 Hz and 1,920 
pulses). Neuronal expression of p75
NTR siRNA but not scram-
bled siRNA prevented synaptic depression. As a control, ex-
pression of p75
NTR siRNA in postsynaptic muscle cells did not 
prevent the depression (Fig. S5 B). These data indicated that 
endogenous proneurotrophins, most likely pro-BDNF (because 
there is little NGF and NT4 in muscle cells at this stage [Xie 
et al., 1997], and NT3 does not have a strong proneurotrophin-
binding domain), released by muscle cell were sufficient to   
induce synaptic depression when strong train stimulation was 
applied to innervated muscle cells.
The failure of mild stimulation (1 Hz for 30 s) to induce 
synaptic depression in control synapses could be caused by either 
an insufficient amount of pro-BDNF secreted and/or a rapid con-
version of some of the secreted pro-BDNF to mBDNF. To elevate 
pro-BDNF in the synaptic clef, we applied a cocktail of protease 
inhibitors before postsynaptic depolarization (Fig. 6 A), thereby 
preventing the conversion of pro-BDNF to mBDNF. Baseline 
synaptic currents were recorded for a period of 10 min followed 
by treatment with protease inhibitors for another 10 min while re-
cording. The postsynaptic myocyte was then stimulated (1 Hz for 
30 s), and synaptic currents were recorded for another 20–30 min. 
The postsynaptic stimulation now induced a marked decrease in 
SSC frequency (Fig. 6 B, right). This result, together with the 
synaptic depression trigged by a stimulation of myocytes express-
ing AA–pro-BDNF (Fig. 5 C), suggests an important role of pro-
teases in pro-BDNF–induced synaptic depression. Several MMPs 
using embryo injection techniques (Yuan et al., 2003). In myo-
cytes expressing cleavable pro-BDNF, mild stimulation (1 Hz 
for 30 s), which elicited no effect in control synapses, now re-
sulted in a significant increase in SSC frequency (Fig. 5 B, left) 
but not amplitude (Fig. 5 D, left). The SSC frequency neither 
increased nor decreased after stimulation in myocytes express-
ing GFP only (Fig. 5 B, right).
We next expressed cleavage-resistant pro-BDNF (AA–pro-
BDNF) in postsynaptic cells. Mild stimulation of myocytes (1 Hz 
and 30 pulses) elicited a completely opposite effect to that ex-
pressing cleavable pro-BDNF, a dramatic decrease in SSC fre-
quency (Fig. 5 C). Further analysis of SSC amplitude indicated 
that postsynaptic depolarization induced a marked decrease in 
amplitude (Fig. 5 D, left) as well as increases in both rise and 
decay times of SSCs (Fig. 5 D, middle and right). These results 
are consistent with the notion that postsynaptic secretion of 
cleavage-resistant pro-BDNF elicited a retraction of presynaptic 
terminals. The observed reduction of SSC amplitude did not   
recover during the course of these experiments (Fig. 5 C), sug-
gesting that the effect of cleavage-resistant pro-BDNF is ir-
reversible. Thus, cleavage-resistant pro-BDNF secreted in response 
to postsynaptic depolarization irreversibly depressed synaptic 
efficacy. The dramatically opposing effects of postsynaptic stim-
ulation suggest that activity-dependent control of pro-BDNF 
cleavage regulates synaptic potentiation or depression.
To further test whether strong depolarization triggers the 
secretion of endogenous pro-BDNF, leading to synaptic depres-
sion, we expressed p75
NTR siRNA (together with GFP) in either 
Figure 4.  Simultaneous recordings of pro-BDNF–induced synaptic depression and imaging of terminal retraction. (top) Time-lapse images showing pro-
gressive retraction of a nerve terminal from a myocyte after pro-BDNF treatment. The dotted circle indicates the myocytes recorded; the dotted line indi-
cates the recording pipette; the arrows indicate the axon terminal. (bottom) Simultaneous recording of SSC recording. The recording shows a rapid and 
persistent decrease in SSC frequency after pro-BDNF application. Note that synaptic depression precedes axonal retraction from its target myocyte. n = 4 
independent experiments. Bar, 10 µm.JCB • VOLUME 185 • NUMBER 4 • 2009   734
Figure 5.  Synaptic modulation elicited by stimulation of myocytes expressing cleavable and cleavage-resistant pro-BDNF. (A) Superimposed differen-
tial interference contrast and GFP fluorescence image showing a motor neuron (N) innervating a myocyte (M) expressing cleavage-resistant pro-BDNF 
(green). The dashed lines indicate the recording pipette. (B and C) Examples (left) and summary (right) of SSC recordings before and after stimulation 735 PRO-BDNF–INDUCED SYNAPTIC DEPRESSION AND RETRACTION • Yang et al.
ocular dominance in the visual cortex (Cabelli et al., 1995, 
1997; Figurov et al., 1996). At neuromuscular synapses, acute 
application of mBDNF elicits a rapid increase in transmitter re-
lease (Lohof et al., 1993), whereas long-term treatment with 
mBDNF promotes synapse maturation (Wang et al., 1995). The 
discovery  that  pro-BDNF  preferentially  binds  and  activates 
p75
NTR (Lee et al., 2001) suggests that pro-BDNF is not a bio-
logically inactive precursor but could elicit through its own re-
ceptor physiological functions distinct from mBDNF. Although 
it was initially questioned whether neurons in the central nervous 
system (CNS) could secrete pro-BDNF (Matsumoto et al., 2008), 
recent studies have shown that CNS neurons primarily secrete 
pro-BDNF in response to depolarization when protease inhibi-
tors were included in the experimental procedures (Nagappan 
et al., 2009; Yang et al., 2009). Using the neuromuscular syn-
apse as a model system, this study has made several interesting 
observations. First, pro-BDNF functionally suppresses synaptic 
transmission and structurally causes axonal retraction. To our 
knowledge, this is the first demonstration of the inhibitory ef-
fects of pro-BDNF on synaptic transmission and connectivity. 
Second, the physiological and morphological effects pro-BDNF 
are mediated by p75
NTR in the presynaptic terminals. This find-
ing, together with the observations that pro-BDNF promotes 
apoptosis in sensory and sympathetic neurons (Lee et al., 2001) 
and facilitates hippocampal long-term depression (Woo et al., 
2005), provides further support for the yin-yang hypothesis (Lu 
et al., 2005): proneurotrophins and mature neurotrophins elicit 
opposite effects through activation of p75
NTR and Trk receptors, 
respectively.  Third,  postsynaptic  stimulation,  which  presum-
ably  induces  the  secretion  of  BDNF  from  the  muscle  cells, 
could either enhance or suppress synaptic transmission, depend-
ing on whether pro-BDNF can be processed. These data provide 
evidence supporting the notion that BDNF is a retrograde mes-
senger that mediates activity-dependent synaptic modulation. 
Finally, blockade of pro-BDNF cleavage, by either mutation 
of its cleavage site or inhibition of extracellular proteases, par-
ticularly the metalloproteases such as MMP3 and MMP9, facil-
itates  synaptic  depression. Thus,  metalloproteases  may  be  a 
major class of proteases mediating the pro-BDNF to mBDNF 
conversion at the Xenopus NMJ. These results identify pro-
BDNF as a key retrograde signal that controls presynaptic de-
velopment and function and suggest that proteolytic cleavage of 
pro-BDNF is an important mechanism controlling the direction 
of BDNF regulation.
Pro-BDNF as a retrograde signal for 
synaptic depression
Decades of research suggest that postsynaptic cells can generate 
positive or negative retrograde signals that affect presynaptic 
are highly enriched at the frog and mammalian NMJs (Kherif 
et al., 1998; Schoser and Blottner, 1999; VanSaun and Werle, 
2000). Because MMP3 and MMP9 have been shown to cleave 
pro-BDNF in vitro (Lee et al., 2001; Hwang et al., 2005), we fur-
ther tested whether synaptic depression induced by postsynaptic 
stimulation in the presence of inhibitors for these MMPs could 
occur. Interestingly, the synaptic depression was induced when 
cells were treated with a combination of MMP3 and MMP9 in-
hibitors but not either one alone. Thus, more than one protease 
might be involved in the pro-BDNF to mBDNF conversion at the 
developing neuromuscular synapses.
Finally, to address whether pro-BDNF truly serves as a 
retrograde signal, we introduced a BDNF morpholino to either 
presynaptic motor neurons or postsynaptic myocytes by embryo 
injection to inhibit the expression of endogenous BDNF. BDNF 
morpholino but not scrambled morpholino was able to reduce 
the levels of endogenous BDNF protein in the whole embryos 
by 40% (Fig. 7 A). Expression of BDNF morpholino in the 
muscle cell but not in the presynaptic neuron completely re-
versed synaptic depression induced by postsynaptic stimulation 
in the presence of metalloprotease inhibitors (Fig. 7 B). Post-
synaptic stimulation in the presence of protease inhibitors also 
induced the retraction of presynaptic terminals (Fig. 8 A). Con-
sistent with the physiological experiments, expression of BDNF 
morpholino in the postsynaptic muscle cells (Fig. 8 B) but not 
in the presynaptic neurons (Fig. 8 C) prevented axonal retrac-
tion. These results suggest that pro-BDNF is derived primarily 
from postsynaptic muscle cells. To confirm that pro-BDNF acts 
on presynaptic p75
NTR to elicit its retrograde effects, we ex-
pressed p75
NTR siRNA using embryo injection. As described in 
Fig. 7 A, synaptic depression was reliably induced by post-
synaptic stimulation in the presence of protease inhibitors (Fig. 7 C, 
second bar group). The synaptic depression was selectively   
prevented by presynaptic (N+), but not postsynaptic (M+)   
expression of p75
NTR siRNA (Fig. 7 C). Expression of scrambled 
siRNA had no effect on this activity-dependent synaptic depres-
sion (Fig. 7 C, last bar group). Collectively, these data suggest 
that, at the developing neuromuscular synapses, activity-dependent 
secretion of endogenous pro-BDNF from postsynaptic muscle 
cells triggers synaptic depression and retraction through p75
NTR 
on presynaptic terminals.
Discussion
Substantial evidence suggests that one of the main functions of 
mBDNF in the nervous system is to strengthen synaptic con-
nection and facilitate synaptic transmission (Poo, 2001; Lu and 
Je, 2003). For example, by activating TrkB, mBDNF facilitates 
LTP in the hippocampus and strengthens the development of 
of postsynaptic myocytes expressing cleavable (Clev.; B) and cleavage-resistant (uncleavable [Unclev.]; C) AA–pro-BDNF. Repetitive depolarization 
was applied to the postsynaptic myocytes through a whole-cell recording pipette (1 Hz for 30 s) under the current-clamp condition (Stim.). Note that 
at synapses expressing cleavable pro-BDNF, SSC frequency increased after postsynaptic depolarization. In contrast, at synapses expressing cleavage-
resistant pro-BDNF, SSC frequency decreased after postsynaptic depolarization. The numbers in parentheses indicate the number of synapses recorded. 
(D) Quantitative analysis of amplitude (left), rise time (middle), and decay time (right) of SSCs before and after stimulation (Stim.) of postsynaptic myo-
cytes expressing cleavable and cleavage-resistant pro-BDNF. The numbers in the bars indicate the number of synapses recorded. *, P < 0.05. (B–D) Error 
bars represent SEM. Bar, 10 µm.
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function (Lo et al., 1994). Using Xenopus nerve–muscle coculture 
as a model, Poo and co-workers have elegantly demonstrated 
that postsynaptic activity is critical in functional suppression 
and, ultimately, the elimination of synapses, a process which is 
critical for proper development of neuronal circuits (Lo and 
Poo, 1991; Dan and Poo, 1992; Lo et al., 1994). They showed 
that postsynaptic depolarization elicited by repetitive stimula-
tion of presynaptic motor neurons (Lo and Poo, 1991), repeti-
tive acetylcholine puffing to the myocyte surface (Dan and Poo, 
1992), or direct injection of depolarizing pulses into postsynap-
tic myocytes (Lo et al., 1994) resulted in a marked and sustained 
reduction in synaptic efficacy at the neuromuscular synapses. 
Furthermore, inhibition of postsynaptic Ca
2+ rise by BAPTA 
prevents synaptic depression (Lo et al., 1994), whereas an in-
crease in cytosolic Ca
2+ by photo-uncaging in the postsynaptic 
myocytes is sufficient to induce persistent synaptic depression 
(Cash et al., 1996). These results suggest that postsynaptic Ca
2+ 
signaling is important for the release of a factor, which in turn 
acts on presynaptic terminals to induce synaptic depression. 
The nature of the retrograde factor remains unknown.
In this study, we provide evidence that one such factor is 
pro-BDNF. Application of exogenous pro-BDNF elicited rapid 
synaptic depression, and such depression was sustained as long 
as pro-BDNF was present. Pro-BDNF also induced the retrac-
tion of presynaptic terminals, albeit in a slower time scale. 
Stimulation of postsynaptic cells expressing cleavage-resistant 
pro-BDNF also induced a sustained depression. A much milder 
postsynaptic depolarization (1 Hz for 30 s) compared with the 
one used previously (Lo et al., 1994; 6 Hz for 20 min) was suf-
ficient to induce depression under our experimental condi-
tions, perhaps because of an elevated level of pro-BDNF by 
overexpression or protease inhibitors that prevent endogenous   
pro-BDNF conversion. Our experiments suggest that the post-
synaptically derived pro-BDNF acts on presynaptic p75
NTR to 
induce synaptic depression. It appears that pro-BDNF is only   
expressed in postsynaptic myocytes, whereas p75
NTR is only 
expressed in presynaptic motor terminals at the Xenopus neuro-
muscular synapses (Fig. S1, B and C). Moreover, both morpho-
logical and physiological effects were completely blocked by 
inhibiting presynaptic but not postsynaptic p75
NTR. It should be 
noted that these effects are not the consequences of motor neuron 
apoptosis because there was no apparent change in cell viability 
24 h after pro-BDNF exposure (Fig. S1 E) and pro-BDNF–induced 
synaptic depression can be completely reversed upon removal 
of pro-BDNF within 5–10 min (Fig. 1 B). We acknowledge that 
there has been no direct evidence so far that endogenous pro-
BDNF is the key factor for synaptic depression in vivo. Finally, 
several recent studies have now confirmed that pro-BDNF is the 
major form secreted from CNS neurons (Nagappan et al., 2009; 
Yang et al., 2009). Although it is practically impossible to dem-
onstrate pro-BDNF secretion at the synaptic cleft, cell surface 
staining with a pro-BDNF–specific antibody showed that de-
polarization induces the secretion of pro-BDNF from myocytes 
(Fig. S4). Collectively, our data support a model showing that 
postsynaptic depolarization triggers the secretion of pro-BDNF, 
which in turn acts on presynaptic p75
NTR to induce synaptic de-
pression and axon retraction.
Figure 6.  Synaptic depression induced by postsynaptic secretion of en-
dogenous pro-BDNF, which is processed by MMP3 and MMP9. (A, top)   
A schematic diagram showing a synapse in which a spherical myocyte (M) 
is innervated by single spinal neurons (N). The dashed lines indicate the 
recording pipette. (bottom) The experimental protocol is shown. After base-
line recording (10 min), protease inhibitors were applied for 10 min. Re-
petitive depolarization was applied to the postsynaptic myocytes through a 
whole-cell recording pipette (1 Hz for 30 s) under current-clamp condition, 
and synaptic efficacy was monitored. (B) Quantitative analysis of depolar-
ization-induced depression caused by treatment with protease inhibitors 
(In.). Note that treatment with protease inhibitors alone or stimulation alone 
did not alter SSC frequency, but stimulation in the presence of protease 
inhibitors markedly reduced synaptic efficacy. (C) Specific MMPs involved 
in depolarization-induced synaptic depression. 50 nM MMP3 inhibitor,   
50 µM MMP9 inhibitor, or both were applied to the cultures for at least   
10 min. Synaptic depression was induced by postsynaptic stimulation (stim.) 
as described in Fig. 4. Note that postsynaptic stimulation in the presence 
of both MMP3 and MMP9 inhibitors but not either one alone triggered syn-
aptic depression. (B and C) The numbers in the bars indicate the number of 
synapses recorded. Error bars represent SEM. *, P < 0.05.737 PRO-BDNF–INDUCED SYNAPTIC DEPRESSION AND RETRACTION • Yang et al.
found that in hippocampal neurons, high frequency (such as 
theta burst) but not low frequency (1 Hz) stimulation preferen-
tially induces the secretion of proteases, which in turn con-
verts pro-BDNF to mBDNF extracellularly in hippocampal 
neurons (Nagappan et al., 2009). Extracellular conversion of 
pro-BDNF to mBDNF has been shown to be critical for hippo-
campal late-phase LTP (Pang et al., 2004). Thus, it is possible 
Proteolytic conversion of pro-BDNF to 
mBDNF at the NMJ
A brief, repetitive presynaptic stimulation has been shown to 
induce a rapid and sustained increase in synaptic efficacy at the 
Xenopus neuromuscular synapses (Wan and Poo, 1999). Curi-
ously, a much higher frequency (40–60 Hz) should be applied 
to induce such a strong synaptic potentiation. We have recently 
Figure 7.  Synaptic depression induced by postsynaptic   
secretion  of  endogenous  pro-BDNF,  which  activates   
presynaptic  p75
NTR.  (A)  Down-regulation  of  pro-BDNF 
by BDNF morpholino. Xenopus BDNF–specific morpho-
lino  (Morph.)  and  scrambled  (Scrm.)  analogues  were 
introduced by embryo injection. Neural tubes were dis-
sected, and proteins were extracted. Western blots were 
performed  using  anti-BDNF  antibodies.  The  blot  was 
reprobed with an antitubulin antibody for loading con-
trols. Note a reduction of pro-BDNF expression in BDNF 
morpholino–injected but not in uninjected (control [Ctl.]) 
or scrambled morpholino–injected embryos (left). Quan-
titative analysis of pro-BDNF expression in four indepen-
dent experiments (right) is shown. The numbers in the bars 
indicate the number of Western blots performed. (B) Effect 
of presynaptic (N+) or postsynaptic (M+) expression of 
BDNF morpholino on depolarization-induced depression.   
(C) Effect of presynaptic or postsynaptic expression of p75
NTR 
siRNA on depolarization-induced depression. (B and C) 
The numbers in the bars indicate the number of synapses 
recorded. (A–C) Error bars represent SEM. *, P < 0.05. 
In., inhibitor; stim., stimulation.JCB • VOLUME 185 • NUMBER 4 • 2009   738
transfer–based fluorescence beacon assay, we showed that 
stimulation of motor neurons induced the cleavage of a peptide 
containing the cleavage sequence in pro-BDNF, and such cleav-
age is likely to be mediated by neuronal secretion and/or acti-
vation of MMP3 and MMP9 (unpublished data). Finally, our 
cell surface–staining experiments using antibodies specific for 
pro-BDNF or mBDNF showed that the majority of the secreted 
BDNF is the pro form, and cell surface staining of secreted pro-
BDNF was dramatically increased when depolarization of myo-
cytes was coupled with treatments of MMP inhibitors (Fig. S4). 
We further showed that stimulation of presynaptic neurons   
with glutamate induces an increase in mBDNF staining in the 
surface of myocytes, and such staining was decreased when 
neurons were stimulated in the presence of MMP inhibitors 
(unpublished data). Future studies should be directed toward 
demonstrating that high frequency stimulation induces activa-
tion of MMP3 and MMP9 at the neuromuscular synapses and 
that conversion of pro-BDNF to mBDNF is responsible for ac-
tivity-dependent synaptic potentiation at NMJs and other syn-
apses in vivo.
that postsynaptically derived pro-BDNF could be converted to 
mBDNF by proteases secreted from presynaptic terminals, lead-
ing to synaptic potentiation. Several lines of evidence support 
this hypothesis. First, we found that postsynaptic stimulation 
with our protocol (1 Hz for 30 s) was not sufficient to unmask 
pro-BDNF–mediated synaptic depression. However, treatment 
with protease inhibitors before postsynaptic depolarization in-
duced a robust synaptic depression (Fig. 6 B). Moreover, stim-
ulation of myocytes expressing cleavable pro-BDNF resulted 
in synaptic potentiation rather than depression (Fig. 5 B). Second, 
MMPs are expressed in motor neurons and are highly enriched 
at the NMJ (Kherif et al., 1998; Schoser and Blottner, 1999; 
VanSaun and Werle, 2000). Our electrophysiology experi-
ments showed that more specific inhibitors for metalloproteases 
MMP3 and MMP9 together could unmask the depolarization-
induced synaptic depression (Fig. 7 C), suggesting that MMP3 
and MMP9 may be the proteases that convert pro-BDNF into 
mBDNF upon synaptic activity. Postsynaptic depolarization   
also induced axonal retraction in the presence of protease inhibi-
tors (Fig. 8 A). Third, using a fluorescence resonance energy   
Figure 8.  Synaptic retraction induced by postsynaptic secretion of endogenous pro-BDNF. Nerve terminals were labeled by rhodamine-dextran (red). The 
expression of BDNF morpholino (morph.) is indicated by the green fluorescence. Repetitive depolarization was applied to the postsynaptic myocytes (M) 
through a whole-cell recording pipette (2 Hz for 2 min) under current-clamp condition, and the axon terminal was visualized by time-lapse microscopy.   
(A) Synaptic retraction induced by repetitive postsynaptic stimulation. The axon was filled with rhodamine-dextran to visualize the axon terminal. After 30 min, 
the axon terminal from a stimulated myocyte retracted (indicated by yellow arrows). (B and C) Effect of presynaptic (B) or postsynaptic (C) expression of 
BDNF morpholino on depolarization-induced synaptic retraction. Postsynaptic expression of BDNF morpholino in myocytes blocked synaptic retracted in-
duced by repetitive postsynaptic stimulation (indicated by white arrows). However, presynaptic expression of BDNF morpholino in spinal neurons could not 
block the depolarization-induced synaptic retraction (indicated by yellow arrows). The insets are magnified to show more detailed images of the synapses. 
(A–C) The dotted circles indicate myocytes recorded with a patch electrode. Bars, 10 µm.739 PRO-BDNF–INDUCED SYNAPTIC DEPRESSION AND RETRACTION • Yang et al.
In all experimental conditions, the background noise was <5 pA. A thresh-
old was set to 30 pA for SSCs because very few SSC amplitudes were <30 
pA at the Xenopus NMJ. SSC frequency is defined as the number of SSC 
events per minute. The amplitude, rise time, decay time, and delay of onset 
of synaptic currents were analyzed using Clampfit software (MDS Analyti-
cal Technologies).
Western blot analysis
Xenopus embryos at stage 22 were quickly homogenized in extraction 
buffer I of the ProteoExtract Native Membrane Protein Extraction kit (EMD) 
according to manufacturer’s instructions in the presence of protease inhibi-
tor cocktail (set III; EMD). After high speed centrifugation (14,000 g), the 
supernatants were transferred to a fresh tube containing 300 µl Freon 
(1,1,2-trichlorotrifluoroethane; Sigma-Aldrich), vortexed for 1 min, incu-
bated on ice for 5 min, and centrifuged again to remove yolk protein. To 
measure pro-BDNF expression, immunoprecipitation was performed. The 
supernatants (cytoplasmic fraction) were measured for protein concentra-
tion, and an equal amount of protein was then precleared and immuno-
precipitated by chicken anti–human BDNF (2 µg for 500 µg of total protein; 
Lee et al., 2001) and chicken IgY agarose (Millipore). The precipitated 
materials were subjected to Western blotting using polyclonal anti-BDNF 
(1:1,500; N-20; Santa Cruz Biotechnology, Inc.). For membrane proteins 
(p75
NTR and TrkB), the insoluble pellets after cytoplasmic extraction were 
solubilized in modified radioimmunoprecipitation assay buffer containing 
1% SDS. After centrifugation at 14,000 g to remove insoluble material, the 
supernatant was measured for protein concentration, and 30 µg of protein 
was separated on SDS–polyacrylamide electrophoresis, and blotted onto 
Immobilon-P membrane (Millipore). The blots were probed with the follow-
ing primary antibodies: polyclonal antibody against mouse intracellular 
domain of p75
NTR (1:3,000; provided by B. Carter and P. Barker [Vander-
bilt University Medical Center, Nashville, TN], M. Bothwell [University of 
Washington, Seattle, WA], and M. Chao [New York University, New York, 
NY]), chicken polyclonal anti–human TrkB (1:1,000; provided by L. Reichardt 
[University of California, San Francisco, San Francisco, CA] and M. Chao), 
and  polyclonal  rabbit  antitubulin  (1:5,000;  Abcam).  After  thorough 
washes, the blots were reacted with a secondary antibody conjugated with 
HRP. Signals were detected by the ECL Plus kit (GE Healthcare), exposed 
on HyperFilm (GE Healthcare) for band intensities in linear range, scanned, 
and quantified using ImageJ version 1.37 (National Institutes of Health).
To determine the expression of pro-BDNF in muscle cells, 10–50 mg 
of muscle tissues from the hindlimbs of neonatal mice or Xenopus were   
homogenized in modified radioimmunoprecipitation assay buffer with pro-
tease inhibitor cocktail and sonicated, and proteins were extracted for 15 min 
by increasing SDS and Triton X-100 to 1% and were subsequently cen-
trifuged to remove insoluble materials. The supernatant was estimated for 
protein concentration, and 30 µg of protein was separated on 4–12% Bis-
Tris NuPAGE, transferred to Immobilon-P membrane, blocked using 5% 
BSA in TBST (TBS with Tween 20), probed overnight with chicken poly-
clonal pro-BDNF antibody (Millipore) in 3% BSA/TBST, washed, and de-
veloped  using  anti–chicken  secondary  antibody  conjugated  to  HRP 
(IgY-HRP; 1:5,000; Promega) and the ECL Plus kit.
Time-lapse microscopy
Confocal imaging was performed using an inverted laser-scanning micro-
scope (LSM 510 META; Carl Zeiss, Inc.) with a 25× NA 1.0 or 40× NA 
1.3 oil immersion objective (Plan-Apochromat; Carl Zeiss, Inc.). For dual or 
triple color imaging, excitation lines of an argon laser of 488 nm and two 
helium lasers of 543 nm and 640 nm were used. Fluorescence was de-
tected using a 458/514-nm dichroic beam splitter and a 530–560-nm 
band-pass filter for FITC, a 580–620-nm band-pass filter for rhodamine, 
and a 650-nm long-pass filter for Cy5. With the narrow band-pass filters, 
any crossover or bleed-through of fluorescence was eliminated. Time-lapse 
scanning was performed using LSM 510 imaging system software (Carl 
Zeiss, Inc.). After acquisition, images were processed with the LSM 5 
Image Browser (Carl Zeiss, Inc.) and Photoshop CS software (Adobe). One 
phase-contrast image and subsequent fluorescent images were recorded 
every 5 or 10 min with z-series stack at 1.0-µm intervals. The expression of 
fluorescent dyes or siRNA did not affect axon morphology compared with 
uninjected  controls.  Axons  were  reconstructed  three-dimensionally.  For 
time-lapse confocal imaging, identical settings (acquisition speed, pinhole 
size, laser intensities, dichroics, filters, size of uncaging region of interest 
(ROI), uncaging iterations, etc.) were used except for the gain because of the 
heterogeneity of fluorescence signals. We also tested the photo-bleaching   
effects. Even after 6 h, the level of photo-bleaching was <10% of the fluor-
escence  signal.  Furthermore,  to  circumvent  focal  point  changes  during 
long-term imaging, several z stacks (7–10 stacks) were acquired and later 
Materials and methods
DNA constructs, embryo injection, and Xenopus nerve–muscle coculture
EGFP–pro-BDNF and AA–pro-BDNF–GFP cDNA constructs were made as 
previously described (Egan et al., 2003). Xenopus egg laying was in-
duced by injecting female Xenopus with human chorionic gonadotropin 
hormone (Sigma-Aldrich). Resulting eggs were fertilized with sperm de-
rived from male testis. Morpholinos, siRNA, or cDNAs were mixed with   
fluorescence dye (FITC or rhodamine) or 1 µg/ml GFP mRNA in a 1:1 ratio 
and injected into one of the blastomeres at the 2–4- or 8–16-cell stage 
using the Picospritzer pressure ejector (Parker Hannifin). As such, neurons 
and muscle cells derived from the injected blastomere, which were identi-
fied by their exhibition of fluorescence, underwent changes in the expres-
sion of genes of interest. 1 d after injection, the neural tube and associated 
myotomal tissues were dissected, dissociated in Ca
2+-Mg
2+–free medium 
(58.2 mM NaCl, 0.7 mM KCl, and 0.3 mM EDTA, pH 7.4) for 15–20 min, 
and plated on glass coverslips. Cells were grown for 1 d in culture medium 
consisting (vol/vol) of 50% L-15 medium, 1% fetal calf serum, and 49% 
Ringer’s solution (117.6 mM NaCl, 2 mM CaCl2, 2.5 mM KCl, and 10 
mM Hepes, pH 7.6). After 1 d in vitro, spinal neurons and myocytes form 
synapses ad lib. The mixing of cells derived from injected and uninjected 
blastomeres resulted in the formation of synapses with altered expression 
of genes of interest in presynaptic neurons and/or postsynaptic muscle 
cells, as indicated by fluorescence.
Morpholino and siRNA
Position 45–67 relative to the start codon of the open reading frame, which 
is shared between the two Xenopus p75
NTR genes (p75NTRa and p75NTRb; 
Hutson  and  Bothwell,  2001),  was  selected  (5-AGAGCCAUGUUGGU-
CAGGGCA-3) to generate p75
NTR siRNA. The 23-nt sense and 23-nt anti-
sense strands with two base overhangs (AA) were chemically synthesized 
by Thermo Fisher Scientific in deprotected and desalted form. Scrambled 
p75
NTR siRNA (5-GCUGGCCGAGGCUUAAGAGAU-3) was used as a 
control. Antisense morpholino oligonucleotides, which achieve their effects 
by inhibiting translation initiation through its binding to the 5 untranslated 
region of the target mRNA, were used to down-regulate the expression of 
Xenopus genes. The Xenopus p75
NTR morpholino sequence was 5-CCAT-
GCTGATCCTAGAAAGCTGATG-3. Its scrambled control was 5-CTACTG-
CAAACATGGTACTGCTAGG-3  (invert  antisense).  Anti–Xenopus  BDNF 
morpholino (5-CTCACCTGATGGAACTTATTTTAGC-3), which is specific 
to  Xenopus  BDNF,  and  the  control  morpholino  oligonucleotides  with  a 
scrambled sequence (5-CCTCTTACCTCAGTTACAATGTATA-3) were syn-
thesized by Gene Tools, LLC. To visualize their distributions, all morpholino 
oligonucleotides were tagged with a fluorophore (FITC). The effectiveness 
of p75
NTR siRNA and BDNF morpholino was confirmed by Western blot-
ting (Fig. 2). All of the electrophysiological and imaging experiments on 
synaptic depression and retraction were performed in blind manners such 
that the experimenter did not know whether the fluorescent cells expressed 
siRNAs/morpholinos for scrambled or target genes.
Electrophysiology
Synaptic currents were recorded from innervated muscle cells in 1-d-old 
cultures by whole-cell recording in culture medium at room temperature 
(Wang et al., 1995). Neuron/myocyte pairs were selected randomly. For 
recordings of cells with gene manipulations, we performed blind record-
ings followed by fluorescence microscopy to verify whether the mRNA, 
cDNA, or siRNA of interest was expressed in the presynaptic motoneuron, 
postsynaptic muscle cell, or both. The internal pipette solution contained 
150 mM KCl, 1 mM NaCl, 1 mM MgCl2, and 10 mM Hepes buffer, pH 
7.2. The membrane potentials of the muscle cells recorded were generally 
in the range of 55 to 75 mV and were voltage clamped at 70 mV. To 
elicit ESCs, square current pulses (0.5–1 ms and 0.5–5 V) were applied to 
the soma of spinal neurons with a patch electrode filled with Ringer’s solu-
tion at the neuronal soma under loose seal conditions. To depolarize mus-
cle cells, square pulses (pulse duration, 0.5 ms; amplitude, 0.8 nA) at a 
low rate (1 Hz and 30 pulses) were applied to the myocytes using the   
recording patch pipette. This stimulation protocol did not elicit synaptic   
depression when only GFP is expressed postsynaptically. In contrast, a 
stronger protocol (1 Hz and 1,920 pulses) similar to the one that Lo et al. 
(1994) used (2–6 Hz and >900–3,000 pulses) induced a pronounced 
synaptic depression in GFP-expressing myocytes (Fig. S4). Thus, the num-
ber of pulses correlates with the degree of synaptic depression.
All data were collected by a patch clamp amplifier (Axopatch 200B; 
MDS Analytical Technologies), with a current signal filter set at 3 kHz. Pipette 
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2 ng/ml of pro-BDNF was used in all of our experiments. The relative po-
tency of pro-BDNF purified from cell lysate, measured by its efficacy on 
synaptic depression at Xenopus neuromuscular synapses as in Fig. 1 A, 
was 5–10 times less than pro-BDNF secreted in the aforementioned me-
dium of HEK293 cell culture.
Simultaneous imaging and recording of synaptic retraction
Synaptic currents were recorded from innervated muscle cells in 2-d-old 
Xenopus nerve–muscle cocultures by whole-cell recording as described in 
DNA constructs, embryo injection, and Xenopus nerve–muscle coculture. 
Repetitive postsynaptic stimulation in the presence of protease inhibitors 
was used to induce synaptic depression (Fig. 6) and terminal retraction 
(Fig. 8). Muscle cells were depolarized (VH from 60 mV to 20 mV for 
300 ms) at 2 Hz for a period of 6 min by injection of whole-cell currents 
into the myocyte under the voltage-clamp condition through the whole cell–
recording pipette. During the entire course of electrophysiological record-
ing, neurons labeled with FITC-dextran were illuminated with brief pulses 
of 488-nm excitation light, and fluorescence images (505 nm to 550 nm) 
were collected on an inverted microscope (TE1000; Nikon) with a 40× 
NA 0.60 air objective (Plan-Apochromat; Nikon) and a charge-coupled 
device (Cascade 512B; Roper Scientific). Brief UV exposure (250 ms) did 
not affect the baseline recording. Fluorescence and bright-field images 
were acquired every 10 min as long as the whole-cell recording was main-
tained and subsequently were processed with IPLab software offline.
Cell survival assay
Cell survival was assessed by using TUNEL labeling (In situ Cell Death   
Detection kit, Fluorescein; Roche). Cultures were fixed in 4% formaldehyde 
in PBS, permeabilized with 0.1% Triton X-100 and blocked with 5% BSA 
in PBS. TUNEL reaction mixture was then added to cultures for 1 h. After 
counting the number of TUNEL-positive and -negative neurons, cell survival 
was defined by the percentage of TUNEL-negative cells compared with 
total cell numbers.
FM 1-43 imaging
For FM dye imaging, the fluorescent styryl membrane dye FM 1-43 (Invitro-
gen) was loaded into Xenopus spinal neurons by applying high K
+ loading 
solution (60 mM KCl, 57.6 mM NaCl, 3.5 mM CaCl2, and 10 mM Hepes, 
pH 7.6; 2 µM FM 1-43) to control or pro-BDNF–treated cultures for 2 min. 
Cells were rinsed extensively with Ringer’s solution to remove membrane-
bound FM dye. Next, fluorescent images of FM dye were acquired by a 
cool charge-coupled device camera (MicroMax 1300; Roper Scientific), 
mounted on an inverted epifluorescence microscope (IX70; Olympus), and 
analyzed offline using IPLab software. Fluorescence images were taken 
with a 1,000-ms exposure time with a 40× NA 0.55 objective (Plan-
Apochromat; Olympus). The pseudocolor (green) was assigned to fluores-
cent images. FM dye destaining experiments were performed as described 
previously (Ryan et al., 1993; Je et al., 2005) with minor modifications. In 
brief, FM 1-43 was loaded into neurons as described above for 2 min, and 
cells were washed extensively with Ringer’s solution. Fluorescence images 
were acquired at a rate of 0.2 Hz with a 250-ms exposure time with a 40× 
NA 0.6 objective. After acquiring five images (10 s) as a baseline, FM 1-43 
destaining was initiated by rapid perfusion of high K
+ loading solution 
(60 mM KCl, 57.6 mM NaCl, 2.0 mM CaCl2, and 10 mM Hepes, pH 7.6). 
The image data were stored and analyzed offline by IPLab software.   
Fluorescence intensities were extracted from time-lapse images of individual 
boutons. The data were normalized to background fluorescence and fitted 
by single exponential curves, and time constants () were obtained and   
averaged in Excel (Microsoft).
Online supplemental material
Fig.  S1  shows  expression  of  pro-BDNF,  p75
NTR,  and  TrkB  in  Xenopus 
nerve–muscle coculture system and in vivo and survival of spinal neurons 
upon pro-BDNF treatment using TUNEL assay. Fig. S2 shows the effect of 
pro-BDNF on FM 1-43 destaining kinetics. Fig. S3 demonstrates persistent 
synaptic retraction after pro-BDNF washout. Fig. S4 shows pro-BDNF sur-
face staining on Xenopus nerve–muscle cocultures. Fig. S5 indicates synap-
tic depression triggered by different postsynaptic depolarization protocols 
and shows that p75
NTR knockdown in spinal neurons blocked synaptic de-
pression induced by stronger postsynaptic stimulation (1 Hz and 1,920 
pulses).  Online  supplemental  material  is  available  at  http://www.jcb 
.org/cgi/content/full/jcb.200811147/DC1.
We thank Drs. Phillip Nelson, Neil Shneider, Keri Martinowitch, Jay Chang, 
Angela Mabb, Thomas Newpher, and Newton Woo for their thoughtful 
comments and suggestions, and Regeneron Pharmaceuticals for providing 
projected to two dimensions with maximum intensity. After image acquisi-
tion, threshold was adjusted for better visualization. Finally, we used high 
powered differential interference contrast optics to trace the remnant of the 
axon terminals to ensure the entire axon arbor was efficiently visualized.
Quantification of axon elongation and retraction
Using the ROI tool from the IPLab software (BD), the optical center of mass 
(COM) of a given axon terminal was identified. For single muscle-innervating 
axons, the distances between the COM of the AChR fluorescence sig-
nal and the COM of the axon terminal were determined at different time 
points after pro-BDNF application. The extent of retraction (or elongation) 
was calculated by subtracting the distance at a given time point after neu-
ronal stimulation with that before stimulation. The values for multiple axons 
in the same condition were pooled and averaged. Synaptic retraction was 
defined as withdrawal of nerve terminal from synaptic site by 1 µm.
Immunofluorescence staining of Xenopus cultures
Xenopus neurons and muscle cells grown on coverslips were washed with 
PBS, fixed with 4% paraformaldehyde in PBS for 30 min at room tempera-
ture, incubated in 0.1% NaBH4 (sodium borohydrate) in PBS to reduce   
autofluorescence, and blocked using 5% nonfat milk in PBS for 60 min. For 
pro-BDNF surface staining, the cultures were incubated with pro-BDNF   
antibody (1:200; Millipore) in 5% nonfat milk overnight at 4°C. The cultures 
were then reacted with secondary antibody (Alexa Fluor antibodies from 
Invitrogen) for 1 h. After PBS washes, the coverslips were rinsed with water 
and then mounted on medium containing Mowiol 4-88 and the antifade 
DABCO (1,4-diazabicyclo[2.2.2]octane). Images were acquired using a 
63× NA 1.4 oil Plan-Apochromat lens and multitrack option in the LSM 
510 Meta for all samples on the same day under identical conditions (laser 
power, pinhole, gain, and offset for two different colors). For quantitative 
analysis of pro-BDNF fluorescence signals, we first subtracted background 
and adjusted the threshold to 50% over the background fluorescence inten-
sity by averaging the numbers obtained from three nonfluorescent areas. 
The dynamic range of fluorescence intensity values was confined to arbitral 
fluorescence unit in 8 bits (in pixels, 0 [minimum]–255 [maximum]) to nor-
malize fluorescent signals from differently treated groups. Mean intensities 
from all positively stained spots along the synaptic area in a myocyte were 
obtained using the ROI tool in IPLab software. Then, the mean intensity val-
ues of fluorescence signal in a given synapse were averaged and pre-
sented as mean ± SEM.
For immunofluorescence staining of TrkB, p75
NTR, and intracellular 
pro-BDNF, similar procedures were used except that cells were permeabi-
lized with 0.05% Triton X-100 in PBS for 5 min. After blocking, cells were 
incubated with TrkB antibody (1:50; Santa Cruz Biotechnology, Inc.) or 
p75
NTR intracellular domain antibody (1:100; provided by B. Carter) over-
night at 4°C.
Purification of recombinant pro-BDNF
To generate pro-BDNF with impaired proteolytic cleavage, residues RR 
were mutated to AA using PCR, and six His residues were added at the   
C terminus. This cDNA construct was subcloned to the expression vector 
pcDNA, and stably transfected HEK293 cells were isolated after selection 
in G418-containing medium. Cells were incubated in serum-depleted 
media for 18 h, and the media were collected and depleted of cells by centri-
fugation. His-tagged cleavage-resistant pro-BDNF was purified by Ni-bead 
chromatography (Xpress System Protein Purification; Invitrogen) according 
to the manufacturer’s instructions at 4°C overnight and eluted with the use 
of 350 mM imidazole. Fractions containing purified His-tagged cleavage-
resistant pro-BDNF were dialyzed against Xenopus Ringer solution (117.6 
mM NaCl, 2 mM CaCl2, 2.5 mM KCl, and 10 mM Hepes, pH 7.6). Pro-
teinase inhibitors (final concentrations: 25 mM GM6001, 100 nM 2-anti-
plasmin, and 10 µM -amino-n-caproic acid) were added to the dialyzed 
protein, and purified proteins were stored at 80°C before use. Purifica-
tion was monitored by Western blotting using antibody against mBDNF 
and silver staining using mBDNF as a standard.
To generate a large quantity of pro-BDNF for in vivo injection experi-
ments, we generated a stable clone of HEK293 cells using the lentiviral 
vector pLV1 expressing HA–pro-BDNF from a cytomegalovirus promoter. 
The HEK-LV/HA–pro-BDNF cells were lysed in buffer containing 50 mM 
Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% NP-40, and protease inhibitors, 
sonicated, and centrifuged to remove any insoluble material. HA-tagged 
pro-BDNF was purified on the anti-HA affinity matrix (Roche). Protein purity 
was verified by silver staining (a single band), and its identity was con-
firmed by Western blot analysis using polyclonal anti–pro-BDNF antibody 
(1:1,500; N-20; Santa Cruz Biotechnology, Inc.). The concentration of 
pro-BDNF was determined by Bio-Rad Laboratories protein assay, and   741 PRO-BDNF–INDUCED SYNAPTIC DEPRESSION AND RETRACTION • Yang et al.
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